The Human Gut Microbiome: A Physiological System Approach by Banks, David & NC DOCKS at The University of North Carolina at Greensboro
David Banks 
The Research Process 
In 2011, when I first began my investigation into which undergraduate institution I would 
be calling home for the next four years, I visited UNCG and immediately recognized an 
atmosphere of academic momentum. An image of a library with nine floors and an endless 
number of volumes to explore became timeless in my mind; however, in no way could I have 
imagined the assistance and guidance it has given me over the past three years in terms of my 
research interests. 
In developing this research synthesis, specifically, I found great support and guidance in 
the library staff and in resources that went far beyond the stacks of books I had been so eager to 
delve into once before. I have always been interested in literature review and analyses; this even 
deterred my ability to decide which major I would finally settle with. One day, however, I 
decided to migrate to the fifth floor and settle in for a late night of studying and found an entire 
collection tailored to biological and chemical science. I was floored, and it was here that I would 
stumble across a book, Neuroimmunology, that displayed an intersection between the brain and 
microbes I did not know existed. So, I took a Microbiology course and decided to contract it for 
Honors credit. Without this book, I am not sure if I would have been influenced in such a way as 
to change my projected research focus after obtaining my Bachelor's degree. This work, coupled 
with the encouragement and suggestions ofDr. Cannon of the Biology Department, fortified my 
decision to explore the human gut microbiome and how it affects the human body as a whole. 
In the process of developing an Honors contract thesis, there were two databases made 
available to me, as a UNCG student, through Jackson library that helped me greatly in searching 
for primary literature on the topic at hand: Academic Search Complete and PubMed. It was 
actually Prof. Kellam, a librarian I had taken a political science class with before that has been a 
great mentor and source of academic motivation, who revealed to me that these databases would 
likely assist the greatest in terms of recent literature. It was as if I had an actual memoir of 
scientific development at my fingertips. These databases, along with several members of the 
staff who helped me physically locate several books that were used for background information 
in the first several pages of my paper, enabled me to write a paper worthy of Honors credit. 
With research, I have come to realize through this process, frustration is going to occur. 
The resources that provided me with the information necessary to formulate an argument and 
support its foundation also posed a challenge: sifting through what seemed like an endless 
number of candidate pieces. I was up to the task but, at times, it was difficult to decide which 
articles would coincide with my argument, while still keeping in mind the necessity to 
acknowledge and refute the claims of authors who may not have agreed with what I was trying to 
synthesize. When I began seeing this as an opportunity for virtual collaboration instead of a 
daunti1,1g task, it became much easier and more productive. In this way, the process enabled me 
to take a lesson with me in completing future projects: to view every resource as a candidate for 
interview and to choose the ones with which I would like to work in partnership in making this 
new product. Although challenges existed, they provided a learning experience I believe was 
necessary in order for academic and pre-professional maturation. 
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I. The Stage 
Perhaps some of the most complex disorders that have been observed in humans are those 
that concern emotion and processes of the human brain. The pathway between stimulus and 
response in cases of depression and anxiety is one that can take many directions depending on 
the patient in question; for this reason, psychiatry has provided interesting modes by which 
pathology can be studied outside of a one-to-one causal relationship. Given the expected 
lifespan of the average individual and the decades through which different disorders can emerge 
and withdraw given changes in environment or situation, determining the cause of such 
pathologies as Chronic Fatigue Syndrome (CFS) or even Obsessive-Compulsive Disorder (OCD) 
can be daunting for any physician. How does one trace a pattern of feeling or behavior back to a 
causal event that may have occurred years before symptoms even emerged? In an age where 
Post-Traumatic Stress Disorder (PTSD) continues to gain relevance in light of a world at war, 
such questions must be asked. The lives of patients and their families depend on the ability of 
scientists to uncover pathways that can be manipulated to produce some treatment option or cure. 
After Dr. James Greenblatt was sought out by the parents of a young girl named Mary who had 
been diagnosed with a mixture of psychiatric disorders, including OCD and Attention Deficit 
Hyperactivity Disorder (ADHD), and treated with a range of psychotropic drugs that had 
remained largely unhelpful, his mode of thinking was able to change her quality of life (James 
2013). He turned to her stomach as a possible root of the problem. 
One may not expect a trip to the psychiatrist to include a survey of questions aimed at 
ascertaining his or her digestive health; however, Dr. Greenblatt employed this strategy and, 
because of his conclusion that the symptoms that were manifesting in the emotive regions of 
Mary's brain might actually originate from an imbalance in her gut microflora composition, was 
able to prescribe a twice-daily dosage ofprobiotic that alleviated Mary's symptoms altogether. 
His assumption stemmed from an elevated level of metabolite HPHP A in her urine, a byproduct 
of the metabolic pathways of Clostridium species. Dr. Greenblatt's reasoning further developed 
from his ideas concerning the connection between the human gut and brain, an interface that had 
once been deemed a one-way street. By reversing this line of thinking and implementing a 
treatment plan that assumed a gut-to-brain avenue of communication, Dr. Greenblatt was able to 
treat Mary's symptoms, thereby continuing a thought that the gut microbiome plays more of a 
role in the human body than previously thought. While Dr. Greenblatt's treatment of Mary's 
condition constitutes an isolated case where an assumed role by the human gut microbiome 
existed, many clinical studies have also contributed to the belief behind this linkage. 
The treatment of depression or anxiety as symptoms associated with some larger pathology 
has become a forefront of medicine and patient care. Chronic Fatigue Syndrome {CFS) is a 
functional somatic disorder marked by intermittent cycles of severe fatigue, often coupled with 
cognitive dysfunction and/or gastrointestinal disturbances. In fact, half of all CFS patients meet 
the criteria for Irritable Bowel Syndrome (IBS) diagnosis and a similar fraction meet the criteria 
for an anxiety disorder and/or major depressive disorder diagnosis (Rao 2009). The connection 
between the gut and brain are certainly noticeable in patients suffering from CFS. In a 2009 
study, this connection was tested by defining some relationship between the introduction of a 
probiotic and emotional symptoms experienced by patients suffering from CFS. 
In a pilot study, thirty-five patients, twenty-seven females and eight males, were scored and 
chosen based on scaled inclusion and exclusion principles outlined by the researchers and 
included such criteria as the ability of participants to withstand an eight-week study. At the 
beginning of the study, each patient was evaluated using the Beck Anxiety Inventory (BAI) and 
Beck Depression Inventory (BDI), two qualitative psychiatric assessments for anxiety and 
depression respectively, and a fecal sample which was tested for total aerobe, anaerobe, 
Lactobacillus spp, and Bifidobacteria spp counts. In this way, despite a small sample size, the 
study employs by qualitative and quantitative modes of analysis. For an eight-week period, after 
each meal or three times daily, patients consumed the contents of an unmarked container, one 
type which was a placebo or the other which contained eight billion colony forming units (CFUs) 
of Lactobacillus casei strain Shirota (LcS). After the eight-week period was complete, patients 
were again assessed using BAI, BDI, and fecal analysis by the same methods. While 37.5% of 
patients in the control group exhibited an increase in Bifidobacteria and 43.8% in Lactobacteria, 
out of the patients receiving the probiotic, 73.7% of patients saw a significant increase in both. 
BAI results showed a significant decrease in anxiety symptoms in patients receiving the 
probiotic compared to those receiving the placebo, as supported by a significant statistical 
difference between the two groups (Rao 2009). 
In this study, one can see a clear correlation between microbiome composition and symptoms 
associated with pathology, specifically one that connects neuropsychiatry and gastroenterology. 
However, complete causation cannot be concluded because the mode of symptom alleviation in 
CFS patients in this study may have diverged from a one-way-street type of thinking and the 
small sample of patients assayed leaves room for speculation. For instance, one could argue that 
the probiotic may have increased bowel function thereby alleviating symptoms associated with 
anxiety; however, this avenue between independent and dependent variable, or probiotic and 
symptom alleviation, was not investigated in this study specifically. The avenue between 
independent and dependent variable does not change the fact that one still has some resonant 
effect on the other, and such is the case in this instance. The role of the gut microbiome cannot 
be ignored and because of this, understanding its composition and development is crucial to 
discovering new connections between this part of the body, perhaps a human physiological 
system on its own, and pathology. 
II. Diversity and Development 
Before one can begin to clearly understand how the gut microbiome is linked to human 
pathology through interaction with other human physiological systems, one must first ascertain 
the composition of the gastrointestinal (GI) tract: what constitutes this structure and the 
microorganisms residing within? The GI tract is a tube approximately eight meters long 
extending from the mouth to anus; therefore, this tubular passage is open to the external 
environment. Although the GI tract is composed largely of muscle and mucous membrane, its 
associated structures and organs include the esophagus, stomach, small and large intestine, 
pancreas, gallbladder, liver, appendix, colon, and rectum. By association with these organs 
alone, one can conclude that the GI tract plays a major role in the digestion and processing of 
materials consumed through one's mouth or that have entered by some other means, via 
gastronomy tube for instance. It is within the GI tract that ingested materials are converted into 
absorbable forms via mechanical digestion by chewing and chemical digestion by pH fluctuation 
and enzymatic activity (Mullen 2011 ). In this way, nutrients are utilized; without this step, these 
vital substances would simply pass through the body and be excreted because transport 
mechanisms do not exist for many larger molecules. Because of the presence of many enzymes 
targeted at degrading all types of macromolecules and a pH of approximately two because of its 
hydrochloric acid composition, the human stomach also serves as a bottleneck through which 
many microorganisms, besides those evolutionarily-tailored to this type of environment, cannot 
pass without degradation and death. Therefore, discussion of the gut microbiome often refers to 
those microbes that inhabit the lower GI tract, specifically the colon, and small and large 
intestines. 
What microorganisms constitute the gut microbiome and how did they come to reside here? 
The answers to these questions are much more involved than a simple list of microorganisms 
constructed by fecal sample analyses, especially when it is already known that the composition 
of the gut microbiome varies with environmental conditions. The composition of the gut 
microflora community of an individual from a developing country such as Somalia is likely far 
different than that of an individual from a developed country such America or Switzerland. In 
fact, such studies have proven just this. A 2011 study aimed at discerning core similarities and 
differences between gut microbiome populations between individuals did so by analyzing side-
by-side DNA homology data via the Sanger method. Data obtained from twenty-two individuals 
of six different nationalities, including those from America, Spain, and Japan, were analyzed by 
these methods. The environment of the human gut microbiome is, in fact, the human; therefore, 
this study utilized quantitative metagenomic methods of data collection and analyses targeted at 
ascertaining commonalities of the following characteristics between gut micro biomes of 
individuals of different nationality: the number of different groups and the abundance of each 
group. While many themes were ascertained concerning the composition of the microbial 
communities of the gut, three main clusters of bacteria, or enterotypes, were developed that 
correlated strongly with metabolic activity. Differences did exist depending on nationality; for 
instance, individuals of Japanese origin hosted gut microbiomes consistent with the first 
enterotype categorized ( Arumugam et al., 2011 ). However, the development of any enterotypes 
at all indicates the presence of a core population derived in each human GI tract, lending itself to 
the idea that some homologue community exists among humans that has developed alongside the 
human species through evolution. 
The existence of homologous structures has contributed to the understanding ofhow 
evolution has progressed over billions of years; in a similar way, a homologous gut microbiome 
reveals an understanding and confirmation about the processes we already associate with this 
area of the body. A core similarity between microbe populations in the human gut, across the 
globe even, is an indicator that the functions served by specific genus and species groups have 
arisen as a result of some specific function they perform, and due to interactions between 
microbe species and the larger human body. In essence then, the microbiome serves as vital a 
function as the pathways that allow for sight or hearing. Interactions between cells along a 
pathway, through neurotransmitters and other signaling molecules, allow for a response at the 
organismallevel, guided by a distinct nervous system. The existence of this organization across 
all individuals of the human species, as a homologue, shows that these cells are present and vital 
to the function they serve. Without them, function would cease. Similarly, a homologous gut 
microbiome indicates that the functions served by this system are vital to the success of the 
organism through evolution. In other words, if the human gut microbiome has evolved as a 
homologue within the human body, its absence would serve a decrease in fitness that would lend 
any human "behind on the times" in terms of the evolutionary survival of the fittest outlined by 
Charles Darwin decades ago. 
The idea that the microorganisms present during adulthood originate from the materials 
ingested through adolescence would fail to recognize that a distinct microbiome exists at infancy 
and develops from that point in a successional and coordinated fashion much like human cell 
differentiation occurs during gustation. Therefore, the differences in microbial composition 
between individuals of American and Japanese origin noted above would not come as a result of 
different diets associated with each region alone. Another 2011 study, instead of ascertaining the 
similarities and differences among human gut microbiome composition across nationality, 
investigated the development of gut microbiome composition through time, starting at infancy 
(Koenig et al., 2011 ). Through this investigation, researchers were able to ascertain what 
changes in the gut microbiome occur through time and as a result of what events; if one is to 
understand the current state of any system in the body, defining events associated with the 
development of that system are crucial. Without understanding how red blood cells of the 
cardiovascular system originate in the bone marrow and develop through denucleation, for 
instance, the presence of nucleated blood cells in a fetal blood sample might not lead to a correct 
diagnosis of leukemia (Hermansen 2001 ). One can find an analogy in the homologous gut 
microbiome: without understanding how the community started and developed through time, 
how can one determine the reason for current microbiome composition in relation to metabolic 
changes associated with such pathologies as IBS, celiac disease, or Crohn's disease, digestive 
diseases associated with inflammation or infection of the GI tract wall? In 2004, digestive 
disease was determined to be the underlying cause of almost 250,000 deaths in the US alone 
(Everhart 2004 ). Because of the mortality rate due to pathologies associated with changes in the 
gut microbiome, analyzing how such a system changes and develops outside of pathology is vital 
to understanding what goes wrong when pathogenesis does occur. 
In the 20 11 study introduced above, sixty healthy infants were recruited for a study in which 
fecal samples were taken regularly over a 2.5-year timeframe. Fecal samples were analyzed by 
454-pyrosequencing to determine microbial composition, which produced over 300,000 16S 
rRNA sequence profiles. Twelve fecal samples were further sequenced for DNA homology, 
allowing the researchers to further identify the types of bacteria present. From these findings, 
researchers were able to conclude that the infant gut microbiome starts from exposure to the 
mother's vaginal and fecal microbiota during birth. During early infancy, Bifidobacteria are 
abundant, largely due to their ability to digest milk oligosaccharaides. However, before the 
introduction of solid foods, fecal sample analysis indicated the presence of functional genes 
involved in plant polysaccharide metabolism. As solid foods are introduced, the infant gut 
microbiome begins developing into its later adult composition via the following changes: a 
sustainable increase in Bacteroidetes, and an increase in functional genes coding for enzymes 
that contribute to carbohydrate metabolism, biosynthesis of vitamins, and degradation of 
xenobiotics. Additionally, this research included a case study of a young male infant through an 
equal 2.5-year timeframe, which indicated gut microbiome composition changed over time in 
coordination with life events such as fever, and that the microbes present were not randomly 
associated but interacted with each other as indicated by ecological tests such as the C-score and 
checkerboard measures. After referencing the OTU-based cluster analysis, researchers used the 
above statistical methods to conclude that species occupying the infant gut existed according to 
community assembly rules. High C-score and checkerboard values, which test if species exclude 
one another from shared niches and if species exist in the gut that never co-occur, indicated that 
the gut microbiome species exist through interaction rather than random association (Koenig 
2011). 
III. A Physiological System Approach 
From the findings of this study, one can conclude several things about the human gut 
microbiome. A human gut microbiome exists during infancy even before solid foods are 
introduced, and development occurs through succession of microbial species and interaction with 
their environment. Interestingly enough, these themes reside in other human physiological 
systems as well, including the nervous system. A nervous system exists long before the addition 
of reaction-producing stimuli and neurons within the brain increase in number and differentiate 
over time until the adult mode of brain function is reached (Tucker 2013 ). In this instance, we 
see a clear similarity between the human gut microbiome and a distinct physiological system. To 
go a step further and define the human gut microbiome as such, however, several more factors 
must be analyzed. Associated pathology via disruption of homeostatic function, including 
correction via transplantation, communication with other areas of the body through inter-
systemic interaction, and coordinated communal action in response to stimuli, as outlined by a 
series of studies, are all marked characteristics that allow one to define the human gut 
microbiome as a unique human physiological system. 
i. Homeostasis and Pathology 
As already noted, the composition of the gut microbiome is associated with such conditions 
and pathologies as CFS. However, a distinct mode of thinking that connects the human gut 
microbiome with a disruption in homeostasis, indicating that it plays a usual role in maintaining 
it, and pathogenesis is necessary for one to define it as a human physiological system, as opposed 
to conclusion by mere correlation. A 2011 study attempted to discern such a connection between 
the gut microbiome of mice, a prime model organism for human homeostatic regulation, and the 
onset of autoimmune encephalomyelitis via impairment of normal immune functioning. All 
mice used were of a model exhibiting relapsing-remitting autoimmune encephalomyelitis, a 
pathology originating in CD4+ T cells and myelin oligodendrocyte glycoprotein-autoantibody-
producing B cells of the immune system. In this study, mice devoid of gut microbiota were 
compared to those who contained commensal flora isolated to prevent disruption of the study by 
introduction of pathogenic species that could have produced an undocumented immune response 
leading to pathogenesis. Those mice devoid of gut flora exhibited no spontaneous generation of 
expected pathology, lending the researchers to conclude that the existence of commensal flora is 
necessary for the autoimmune response responsible for the pathogenesis outlined. Additionally, 
when mice devoid of gut microflora were recolonized with commensal microorganisms, the 
relapsing-remitting autoimmune encephalomyelitis pathology generated within several weeks, 
further indicating that the pathology is at least partly dependent on the presence of a commensal 
gut microbiome (Berer 2011 ). This pathology in mice, because of its mode of destruction of 
myelin in neurons, serves as a model of multiple sclerosis in humans, and indicates a clear 
dependence of homeostatic mechanisms in pathogenesis. 
Other studies have also clearly linked the human gut microbiome with disruption of 
homeostasis and pathogenesis in areas throughout the human body; one such study investigates 
this criteria by analyzing the effectiveness of fecal transplantation in returning the human 
digestive system to its original state of function in the context of recurrent Clostridium difficile 
infection. The human GI tract can become invaded by the species Clostridium difficile if normal 
immune response is compromised or resistant strains enter the gut; such infections are common 
in hospitals and long-term care facilities. Antibiotic treatment of this infection may seem an 
obvious form of treatment and one might expect this treatment to be fully effective in eliminating 
infection; however, recurrence of infection arises in about half of all patients given this treatment 
option. Therefore, in 2012, researchers sought to elucidate the effectiveness of fecal 
transplantation in voiding the GI tract of reoccurring Clostridium difficile infections. In 70 
patients, donor feces was inserted into the cecum during colonoscopy. In all patients, no 
immediate complications were observed, an important factor in determining the efficacy of any 
new treatment option. Within 12 weeks, all patients not infected by strain 027 Clostridium 
difficile saw a complete alleviation of symptoms and 89% of patients with infections by strain 
027 Clostridium difficile had similar results. In this instance, the fecal transplantation was not 
only effective at eliminating the recurrent infections, but even infections caused by a known 
virulent strain. Four patients did not respond, having previous comorbidity, and died of colitis. 
Within the first year, four patients whose symptoms were alleviated experienced relapse and 
were treated again, two by fecal transplantation and two by antibiotics; in all instances, 
eradication of the reoccurring infection was successful. 
In this instance also, the gut microbiome is connected to a pathology associated with a 
disruption in homeostasis. Reoccurring infection by varying strains of Clostridium difficile, 
including those marked by virulence, serves as the example pathology in this case. In the study 
examining the role of the microbiome in pathogenesis of relapsing-remitting autoimmune 
encephalomyelitis in mice, a positive-trend relationship was observed between microflora and 
pathology. In the presence of gut microflora, pathogenesis occurred; however, in its absence, 
pathology remained absent. In discussing fecal transplantation in the context of categorizing the 
human gut microbiome as a unique physiological system, however, a negative-trend relationship 
is noted. Despite these differences in correlation, both cases still connect the gut microbiome 
with disruptions in homeostasis, either contributing or correcting this disruption. One could 
argue that the positive-trend observed between this gut flora community and pathology disallows 
its classification as a physiological system; however, it is the red blood cells of the circulatory 
and respiratory system, altered by inheritable genetic mutation, that serve as agents of symptoms 
caused by sickle cell anemia, despite the usual vital function they perform (Ravindra et al., 
2012). If cells of a physiological system serve as agents of pathology, their role in homeostatic 
disruption is even more obvious; this quality does not exclude them from the physiological 
system within which they function. Similarly, classification of the human gut microbiome as a 
physiological system is only confirmed by having both of the studies discussed above side-by-
side, revealing that this system has an intimate relationship with pathologensis at both ends of the 
spectrum. 
ii. Inter-systemic Communication 
How is it that the presence or absence of commensal microflora in the gut can contribute to a 
disruption of a homeostasis leading to pathogenesis in an area of the body as far away as the 
central nervous system, as in the case of relapsing-remitting autoimmune encephalomyelitis? 
Some form of communication must occur between this area of the body, possibly mediated by 
some other systemic response, and the central nervous system: a conclusion that was made by 
Dr. Greenblatt in his treatment of Mary's symptoms and the researchers that tested the 
connection between the introduction of a pro biotic and alleviation of symptoms associated with 
emotion in CPS patients. Inter-systemic communication producing some response as a result of 
a stimulus is a hallmark of physiological systems within the human body, and is a characteristic 
shared by the gut microbiome. Such connection and communication is obvious when effects on 
the adrenal gland, a landmark of the human endocrine system, are observed in patients suffering 
from sepsis. In these cases where toxins are introduced into the human body by pathogenic 
microbes, dysfunction of the adrenal gland occurs by multiple modes, including inflammation 
and cell death. In a 2013 study, LPS-induced inflammation was set in mice and, as a result, 
overexpression of cytokines and chemokines and a mass recruitment of lymphocytes into the 
adrenal gland were all observed, leading to changes in an entirely different physiological system 
(Kanczkowski et al., 2013). In this instance, a communication scheme is offered, connecting the 
immune and endocrine systems through pathogenesis. Such a line of communication also seems 
to exist between the gut microbiome and the nervous system, via interaction with the immune 
system, as indicated by the study examining autoimmune encephalomyelitis in mice outlined 
above. 
The means of communication by which the gut microbiome could lead to pathogenesis in the 
nervous system lies in the proximity between and integration of the GI tract and immune system. 
The physical interface between gut and immunity lies in the gut-associated lymphoid tissue 
(GALT). This system of lymphoid tissue is physically integrated into the wall ofthe GI tract, 
specifically around the intestine. Some may argue that the primary mode of immune response 
occurs via the human circulatory system. Such an argument is feasible given the fact that cells of 
the immune system responsible for targeting and destroying foreign particulate matter and 
pathogenic species travel to their targets through blood vessels spanning the entire human body. 
However, the storage house of these immune cells, including B and T lymphocytes, is the GALT 
(Honjo 2006). The simple proximity between the gut and cells of the immune system is enough 
for one to point to a connection between these systems; however, a simple connection does not 
conclude a specific line of communication associated with inter-systemic interaction between 
physiological complexes. This gap in reasoning is closed when one references such studies as 
that linking micro biota presence and pathogenesis of relapsing-remitting autoimmune 
encephalomyelitis in mice. In fact, the dynamics surrounding communication between the gut 
microbiome and immune system investigated by Berer is only one case of inter-systemic 
communication between the human gut microbiome and other physiological systems; such a link 
also exists between the flora in the human gut and the production of sex hormones, species of the 
endocrine system, which constitute a layer of context surrounding the pathogenesis of 
autoimmune disorders. 
A 2013 study investigated the linkage between the human gut microbiome and the origin of 
autoimmunity, which coincides with the focus of that performed by Berer in 2001; however, the 
mode by which this linkage occurs requires communication via sex hormones according to 
Markle. In this study, nonobese diabetic mice were employed that host spontantaneous, 
immune-mediated annihilation of pancreatic p cells, which causes type 1 diabetes. Male mice 
were protected from pathogenesis when colonized with commensal flora, marked by an increase 
in systemic testosterone levels. Like in humans, a disparity was obvious between the male and 
female mice in terms of type 1 diabetes pathogenesis. However, when maturing female mice 
were colonized with flora from male mice, the micro flora composition of their gut was altered in 
a way that exhibited that of male mice; in turn, systemic testosterone levels increased as 
expected. However, something more interesting occurred. In female mice treated with the flora 
taken from male mice where no type 1 diabetes was observed, autoantibody generation by the 
immune system and inflammation of the pancreatic islet decreased, thereby protecting these 
treated female mice from type 1 diabetes. Not only does this study confirm that transplantation 
of gut microbiota can alter the course of pathogenesis, but it brings into a play a new series of 
communication mechanisms: sex hormones. When microflora composition was altered, sex 
hormone secretion changed in a way that decreased an autoimmunity response required for type 
1 diabetes to emerge. Also tested was the dependence of this phenomenon on the presence of 
androgen receptors, which were required for the effects observed (Markle et al., 2013). 
In other words, the presence of sex hormones alone could not alter pathogenesis; the 
receptors for these molecules were also required, lending to the argument that communication 
definitely occurred between multiple inter-systemic complexes: the gut microbiome, sex 
hormones, and the immune system. One could argue that not all of these players were required 
for the disease state that emerged in these mice; however, without any one of these components, 
even in the presence of the other two factors, pathogenesis failed to occur according this study. 
By this line of thinking, a signaling pathway has been mapped that is disrupted when one 
component, either signaler or receptor, is taken out of the equation; therefore, the conclusion that 
the gut microbiome is involved in inter-systemic communication pathways is clearly supported. 
iii. Communal Response 
One criteria of life is the ability of an organism to sense and respond to changes in its 
external environment, thereby maintaining homeostasis. To say that the system remains 
unchanged in the context of an environment fluctuating in growth factors from second to second, 
however, would be false. Instead, it is the responsibility of the organism and its component 
regulatory mechanisms to sense and respond to these changes via signaling pathways in order to 
keep the organism within internal constraints required for survival. For instance, in vertebrates, 
when the wall of a blood vessel becomes mechanically damaged, some mode of clotting is 
required in order to prevent hemorrhage. The process involved requires a series of different 
proteins in the blood stream that interact with one another in a cascading fashion, eventually 
leading to a clot comprised of platelet and fibrin components. The pathway between wall 
damage and clot, however, requires changes in gene expression that allow for the synthesis of a 
plethora of molecules and complexes, and the ability of these species to react in a cooperative 
fashion. These species include the endothelium, coagulation factors, platelets, and leukocytes, to 
name a few. The ability of these molecules to sense one another and respond to a previous step 
in the coagulation pathway is a hallmark of the circulatory system and its regulatory 
mechanisms. However, as stated, homeostasis does not denote a constant state; in other words, 
the formation of clots is not the only necessary step in allowing for the survival of the organism. 
With fibrinolytic factors, these clots would remain indefinitely and increase at an exponential 
rate near the site of vessel damage (Gailani 2007). The homeostasis loop, then, requires a 
communal response by a series pf proteins and other structures that allows for the fluctuation 
between clot formation and clot degradation, without which the organism could not survive. 
Classification of the human gut microbiome as its own physiological system requires a 
communal response by its components to an outside stimulus, a determining factor exhibited by 
the coagulation pathways that exist in the circulatory system. A signal, the breaking of a vessel 
wall, leads to an intrinsic communication pathway mediated by different coagulation and 
fibrinolytic factors that ends homeostatic maintenance achieved by clot formation and eventual 
degradation. Does such a mode of stimuli and cooperative response exist in the gut microbiome? 
While the specific mechanisms of the circulatory system's hallmark coagulation cascade are not 
replicated by the microbes in our gut, pathways connecting stimuli and cooperative signaling and 
response involving changes in gene expression do exist, according to recent students, 
contributing to the argument that this area of the body can, in fact, be classified as a distinct 
physiological system. One such instance where the gut microbiome collectively receives a 
stimulus, employs some signaling pathway involving changes in gene expression to produce 
some end response involves the gut reaction to xenobiotics, as indicated by a 2013 study. First 
researchers categorized microbes in the gut as inactive or active, and identified Firmicutes as the 
largest cohort of active microbes, using a combination of 16S rRNA sequencing, 
metatranscriptomics, and flow cytometry. This allowed for the characterization of cells in the 
gut prior to manipulation by the introduction of xenobiotics, including eight antobiotics and sex-
host targeted drugs. After the addition of these xenobiotics, fecal sample analysis showed an 
increase in the damaged cell cohort via incomplete membrane lysis. In this instance, one can 
observe a signaling pathway in its most basic form: a drug stimulus, pathways for cell lysis, and 
a response of cell damage (Maurice et al. 2013). 
The study went further in analyzing other changes that took place within the gut 
microbiome after the addition of these substances. Researchers, after organizing the 
metagenomic data into gene clusters, recognized a statistically significant increase in the 
expression of genes that call for drug metabolism, antibiotic resistance, and phage induction 
across all active microbes. In this instance, the gut microbiome has entered into a phase known 
as a "stress response," a series of changes in the cellular machinery and metabolism in response 
to substances or environmental factors that threaten cell integrity and survivability (Maurice et 
al. 2013). In this study, a clear relationship between independent variable, xenobiotic addition, 
and dependent variable, changes in microbe dynamics via physiology and gene expression, can 
be clearly observed. However, some may argue that the results of the study reported thus far, 
despite a noted collective response of the entire microbiome in terms of changes in cell integrity 
and gene expression, do not contribute to the gut microbiome's classification as a unique human 
physiological system due to the fact that no specific genetic-molecular pathway between 
stimulus and response was charted to the extent of other response pathways like the coagulation 
cascade of the circulatory system. Because the researchers were able to identify the specific 
genes that were being activated or overexpressed, specific pathways were actually reported. 
One specific drug administered in this study was Sulfasalazine, a compound that 
decreases bowel inflammation in patients suffering from ulcerative colitis and rheumatoid 
arthritis. Because of the linkages already noted between the gut microbiome and digestive 
diseases marked by inflammation of the GI wall, this drug is a primer in discussing the ability of 
the gut microbiome to respond to some stimulus in a communal manner. The addition of this 
drug led to an immediate increase in the expression of genes encoding for thioredoxins, protein 
involved in oxidation-reduction reactions that is conserved across many species, and nitrate 
reductases, which are enzymes that reduce nitrate to nitrite. These molecules are prime examples 
of species involved specifically in the metabolism of drug products to decrease toxicity or 
convert them to absorbable forms necessary for efficacy (Maurice et al. 2013). In characterizing 
the specific pathway associated with Sulfasalazine addition to the gut microbiome, researchers 
were able to further identify instances where the gut microbiome responds collectively to a 
stimulus. Whether the stimulus was antibiotic or host-targeted drug, the existence of any 
collective response, as generic as partial cell lysis or specific as Sulasalazine metabolism, in the 
microbiome contributes to the argument that this area of the body is a physiological system, 
rather than a collection of individual microbial species surviving and interacting with the larger 
human host without causing any observable effects on homeostasis, exhibiting communication 
with other physiological systems of the human body, or acting collectively to respond to 
different stimuli. 
One might argue that the organisms within the gut merely respond individually, leading 
to a directed response; however, the fact that the organisms that reside in the gut constitute 
thousands of different genus and species is enough to refute this argument. The diversity of 
metabolic pathways and molecule secretion mechanisms between even two species would likely 
prevent the end products of two different pathways from combining into some joint response; 
therefore, the microbes found in the gut survive and interact cooperatively in order to produce a 
systemic response to changes in the outside environment, modeled by the manipulation and 
addition of different stimuli. In fact, this was confirmed by high C-score and checkerboard 
numbers reported by Koenig in 2011 whose contribution has already been discussed in the 
context of gut microbiome development in infancy, indicating that the microorganisms in the gut 
do not exist randomly and independently of one another but actually interact in a commensal 
way, leading to the observable microbial compositions and metabolic characteristics present. 
IV. Conclusions and Clinical Implication 
The criteria for categorizing any grouping or complex of different cell types as a unique 
physiological system of the human body, alongside such college course giants as the circulatory 
and nervous systems, were separated into three larger thematic motifs: 
( 1) An intimate relationship with homeostatic maintenance, as characterized by the 
disruptions associated with pathology and corrections facilitated by transplantation of 
component cells 
(2) Communication with other areas of the body and physiological systems through inter-
systemic interaction, either directly or indirectly through a mediating molecules like 
hormones of the endocrine system 
(3) Collective or majority response to stimuli, be it a specific molecule or change in some 
environmental factor, characterized by a specific pathway involving both genes and 
proteins 
These three criteria were all met by the human gut microbiome, a conclusion supported by 
the results of different research reports from the last four years. For this reason, despite the 
various counterarguments proposed, it is more than called for that scientists begin referring to the 
human gut microbiome as a unique physiological system of the human species. The organization 
of this microbial community under such a title will allow new modes of thinking that will guide 
research in a new direction. If this area of the body is classified as such, studies examining more 
specific instances of inter-systemic communication will allow new insights into pathogenesis. 
Boundaries between the systems will be drawn more clearly and pathways of communication 
mapped with far more detail than before; as a result, changes or disruption in these newly-
discovered genetic and molecular pathways can be manipulated more specifically in the 
laboratory, even down to the specific amino acid sequence of a receptor on a gut microbe, 
allowing for the characterization of pathogenesis unlike before. 
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